Annual General Meeting

Marinomed Biotech AG
Investors & ESG
Annual General Meeting

Ordinary General Meeting 2025

Wednesday, June 11, 2025, at 9:00 am

Premises of DLA Piper Weiss-Tessbach Rechtsanwälte GmbH
1010 Vienna, Schottenring 2-6
(Please refer to the invitation for further details)

Past General Meetings

ALL
2024
2023
2022
2021
2020
2019

(877 KB)

(70 KB)

Resolution proposals of the Management Board and the Supervisory Board 2024 (convenience translation)

(81 KB)

Further information on the first item on the agenda "Approval of the sale of the Carragelose division"

(64 KB)

(143 KB)

(148 KB)

(622 KB)

(81 KB)

(91 KB)

(198 KB)

(25 KB)

(2 MB)

Resolution proposals of the Management Board and the Supervisory Board 2024 (convenience translation)

(101 KB)

(149 KB)

(120 KB)

(141 KB)

(47 KB)

(7 MB)

(4 MB)

(80 KB)

(82 KB)

(19 KB)

(227 KB)

(38 KB)

(349 KB)

(73 KB)

(2 MB)

Resolution proposals of the Management Board and the Supervisory Board 2023 (convenience translation)

(371 KB)

(2 MB)

(384 KB)

(283 KB)

(661 KB)

(245 KB)

Declaration according to Sec. 87 Para. 2 Stock Corporation Act [AktG] incl. CV Hofstädter-Thalmann

(163 KB)

(124 KB)

(8 MB)

(4 MB)

(373 KB)

(97 KB)

(108 KB)

(75 KB)

(34 KB)

(2 MB)

(22 KB)

(332 KB)

(57 KB)

Resolution proposals of the management board and the supervisory board 2022 (convenience translation)

(150 KB)

(92 KB)

(756 KB)

(189 KB)

(2 MB)

(44 KB)

(13 KB)

(28 KB)

(29 KB)

(2 MB)

Resolution proposals of the management board and the supervisory board 2021 (convenience translation) 2021

(205 KB)

(43 KB)

(837 KB)

(144 KB)

(154 KB)

(32 KB)

(46 KB)

(22 KB)

(23 KB)

(938 KB)

(165 KB)

(75 KB)

(1 MB)

(50 KB)

Resolution proposals of the management board and the supervisory board 2020 (convenience translation) 2020

(249 KB)

(26 KB)

(2 MB)

(152 KB)

(143 KB)

(22 KB)

(96 KB)

(50 KB)

(95 KB)

(143 KB)

(1 MB)

(555 KB)

(24 KB)

(21 KB)

(35 KB)

(244 KB)

(260 KB)

(35 KB)

Annual Financial Report (incl. financial statements according to UGB with management report and financial statements according to IFRS) 2018

(2 MB)

(116 KB)

Tobias Meister

Investor Relations

ir@marinomed.com

Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com